Shruthi Ravimohan
About Shruthi Ravimohan
Shruthi Ravimohan is the Scientific Associate Director and Oncology Translational Medicine Team Lead at Bristol Myers Squibb, with extensive experience in molecular biology and immunologic assays.
Company
Shruthi Ravimohan is currently employed at Bristol Myers Squibb as the Scientific Associate Director- Oncology Translational Medicine Team Lead. In this role, she is involved in leading a team focused on translational medicine within the oncology sector.
Title
Shruthi Ravimohan holds the title of Scientific Associate Director- Oncology Translational Medicine Team Lead. This position underscores her leadership in scientific research dedicated to oncology and translational medicine.
Education and Expertise
Shruthi Ravimohan has a diverse and extensive educational background. She earned her Doctor of Philosophy (PhD) in Human Genetics from The Johns Hopkins University School of Medicine. Additionally, she achieved a Master’s in Translational Research from the University of Pennsylvania School of Medicine. She also holds a Bachelor of Science in Genetics from the University of Minnesota. Her expertise includes proficiency in various immunologic assays like multi-parameter flow cytometry, Luminex, ELISA, and ELISPOT assay, as well as extensive experience in molecular biology techniques.
Background
Shruthi Ravimohan has a comprehensive background in research and academia. She has worked as a Research Associate at the University of Pennsylvania, a Postdoctoral Researcher at the Botswana-University of Pennsylvania Partnership, and a Doctoral Candidate at The Johns Hopkins University School of Medicine. She also has experience as a Research Assistant at the University of Minnesota and an Intern at Cargill Dow. Her early education includes high school at Gandhi Memorial International School and elementary and middle school at Jakarta International School.
Achievements
Shruthi Ravimohan has received notable awards including a 2-year NIH-funded institutional career development grant (KL2) in 2016 and a Center for AIDS Research Developmental Award. She has 7 first-author publications in peer-reviewed journals and has co-authored 6 additional publications. Her work has been published in journals such as Lancet Infectious Diseases, Clinical Infectious Disease, and the Journal of Infectious Diseases. She has also written two review articles.